🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Everolimus is an oral mTOR inhibitor with demonstrated preliminary efficacy...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2009-05
Trial ID
NCT00869999
Treatments Being Tested
The primary objective of the study is to evaluate the safety of idelalisib ...
Status
Completed
Location
Clearview Cancer Institute
Start Date
2010-03-25
Trial ID
NCT01088048
The purpose of this study is to assess the efficacy of ruxolitinib against ...
Status
Completed
Location
Incyte Investigative Site
Start Date
2017-06-29
Trial ID
NCT03112603
The purpose of this research study is to test the safety of the combination...
Status
Terminated
Location
Dana-Farber Cancer Institute
Start Date
2010-04
Trial ID
NCT01125293
Treatments Being Tested
This study will be conducted to compare Axatilimab Versus Best Available Th...
Status
Recruiting
Location
City of Hope Medical Center
Start Date
2026-05-20
Trial ID
NCT07124078
Treatments Being Tested
RATIONALE: Everolimus may stop the growth of cancer cells by blocking some ...
Status
Completed
Location
Mayo Clinic Cancer Center
Start Date
2012-03
Trial ID
NCT01334502
Treatments Being Tested
The investigators hypothesized that everolimus-based immunosuppressive ther...
Status
Terminated
Location
National Taiwan University Hospital
Start Date
2011-04
Trial ID
NCT01312064
Treatments Being Tested
This study will be conducted to compare Axatilimab Versus Best Available Th...
Status
Active Not Recruiting
Location
Medical University of Graz
Start Date
2025-06-04
Trial ID
NCT06821542
Treatments Being Tested
This study is an open label, multicenter study with two phases: * Phase I ...
Status
Completed
Location
Service des Maladies du Sang - CHRU de Lille
Start Date
2011-12
Trial ID
NCT01567475
Treatments Being Tested
This research is being done to determine if combining an investigational dr...
Status
Completed
Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Start Date
2012-09
Trial ID
NCT01665768
Treatments Being Tested